If you have any news you’d like to share with us – whether it’s about a fundraiser you’re organising or NETs in the news, please let us know.
22 March 2018
“A new Healthline survey of 1,500 cancer patients, survivors, and caregivers found that 89 percent of people diagnosed with cancer […]
22 March 2018
Thank you to all those who participated in NET Patient Foundation’s research into the potential side effects of somatostatin analogues that […]
Read More about Research into potential side effects of somatostatin analogues
21 March 2018
I attended the European Neuroendocrine Tumour Society -ENETS – Conference last week as a patient representative and hope it may […]
12 March 2018
NETRF awarded six new research grants totaling $1.85 million to leading academic institutions around the world. The goal of the […]
Read More about Neuroendocrine Tumour Research Foundation awards six new research grants
15 December 2017
NPF and NCRAS Public Health England partnership project has been compiling statistics on the incidence, prevalence and survival of NET patients in […]
1 December 2017
BAVENCIO® (avelumab) becomes the first treatment for rare skin cancer metastatic Merkel Cell Carcinoma (mMCC) to be licensed for use […]
10 November 2017
As I trudged numbly from one unprofitable doctor’s appointment to another throughout 2007/8 I didn’t know that not pinning down […]
10 November 2017
Here is my #NetCancer story so far…. On 29 February 2016 I was told that one thing that no one […]
10 November 2017
The International Neuroendocrine Cancer Alliance (INCA) is a global alliance made up of 20 patient advocacy and research groups in […]
Read More about INCA: Unmet needs in global NETs patient community
9 November 2017
Today, the NET Patient Foundation publishes a new report focused on improving outcomes for patients with NETs in Scotland. This […]
7 November 2017
For the all the news from our friends in Scotland please click here: http://mailchi.mp/627f89f0eca7/october-newsletter
26 October 2017
UKINETs are the medical society working hard to improve services and clinical benefits for all patients. We work very closely […]
